{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:37Z","timestamp":1788581557693,"version":"build-2803163510"},"reference-count":25,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7790-26","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:13:34Z","timestamp":1788214414000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of &lt;i&gt;BCR::ABL1&lt;\/i&gt; Positivity in Peripheral Blood Neutrophils Enables the Diagnosis of &lt;i&gt;De Novo&lt;\/i&gt; Blast Phase Chronic Myeloid Leukemia with Additional Structural Abnormalities of the Philadelphia Chromosome"],"prefix":"10.2169","author":[{"given":"Hirotaka","family":"Sakai","sequence":"first","affiliation":[{"name":"Division of Hematology, Internal Medicine, Showa Medical University Fujigaoka Hospital, Japan"},{"name":"Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"},{"name":"Center for Genetic and Chromosomal Analysis, SRL, Inc., Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Apperley JF, Cortes J, Cross NCP, et al. Chronic myeloid leukaemia. In: Haematolymphoid tumors, WHO classification of tumors, 5th ed. Armed F, Cree IA, de Jong D, Fonseca AFA, Goldman-L\u00e9vy G, Lokuhetty D, Eds. International Agency for Research on Cancer, Lyon, 2024: 28-33."},{"key":"2","unstructured":"2. Nardi V, Cassaday RD, Cazzaniga G, et al. B-lymphoblastic leukaemia\/lymphoma with <i>BCR::ABL1<\/i> fusion. In: Haematolymphoid tumors, WHO classification of tumors, 5th ed. Armed F, Cree IA, de Jong D, Fonseca AFA, Goldman-L\u00e9vy G, Lokuhetty D, Eds. International Agency for Research on Cancer, Lyon, 2024: 342-344."},{"key":"3","unstructured":"3. Hu S, Haferlach T, Hodge JC, Khattry N, Radich JP. Acute myeloid leukaemia with <i>BCR::ABL1<\/i> fusion. In: Haematolymphoid Tumors, WHO classification of Tumors, 5th ed. Armed F, Cree IA, de Jong D, Fonseca AFA, Goldman-L\u00e9vy G, Lokuhetty D, Eds. International Agency for Research on Cancer, Lyon, 2024: 125-126."},{"key":"4","unstructured":"4. Hu S, Haferlach T, Hodge JC, Khattry N, Orgel E, Radich JP. Mixed-phenotype acute leukaemia with <i>BCR::ABL1<\/i> fusion. In: Haematolymphoid tumors, WHO classification of tumors, 5th ed. Armed F, Cree IA, de Jong D, Fonseca AFA, Goldman-L\u00e9vy G, Lokuhetty D, Eds. International Agency for Research on Cancer, Lyon, 2024: 206-207."},{"key":"5","unstructured":"5. Arber DA, Orazi A, Hasserjian RP, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140: 1200-1228, 2022."},{"key":"6","unstructured":"6. Vardiman JW, Melo JV, Baccarani M, Radich JP, Kvasnicka HM. Chronic myeloid leukaemia, BCR-ABL1-positive. In: WHO classification of tumors of haematopoietic and lymphoid tissues, revised 4th ed. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Eds. International Agency for Research on Cancer, Lyon, 2017: 30-36."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Duffield AS, Mullighan CG, Borowitz MJ. International consensus classification of acute lymphoblastic leukemia. Virchows Arch 482: 11-26, 2023.","DOI":"10.1007\/s00428-022-03448-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Almaeen AH. Diagnostic challenges of <i>de novo<\/i> acute leukemia with positive BCR-ABL1 fusion: case report and review of literature. J Appl Hematol 10: 149-153, 2019.","DOI":"10.4103\/joah.joah_68_19"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Balducci E, Loosveld M, Rahal I, et al. Interphase FISH for BCR-ABL1 rearrangement on neutrophils: a decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR-ABL1 positive acute lymphoblastic leukemia. Hematol Oncol 36: 344-348, 2018.","DOI":"10.1002\/hon.2416"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takahashi N. Can we distinguish chronic myeloid leukemia presenting in the lymphoblastic phase from de novo Philadelphia-positive acute lymphoid leukemia? Intern Med 49: 2535-2536, 2010.","DOI":"10.2169\/internalmedicine.49.4516"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sumimoto H, Tsujimura H, Ise M, et al. Blast phase of chronic myeloid leukemia presenting lymphoid phenotype with a chronic phase of extremely short duration. Intern Med 49: 1297-1301, 2010.","DOI":"10.2169\/internalmedicine.49.3515"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takahashi N, Miura I, Kobayashi Y, et al. Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy. Int J Hematol 81: 235-241, 2005.","DOI":"10.1532\/IJH97.04095"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sato K, Sakai H, Saiki Y, et al. Cell dynamics during differentiation therapy with all-trans retinoic acid in acute promyelocytic leukemia. Int J Hematol 108: 274-281, 2018.","DOI":"10.1007\/s12185-018-2472-9"},{"key":"14","unstructured":"14. Saiki Y, Sakai H, Uchida A, et al. Leukemic cell kinetics of APL with a novel complex variant t(12;17;15)(p13;q21;q22). Rinsho Ketsueki 61: 103-109, 2020."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sakai H, Miura I, Arai A. Quantitative evaluation of treatment response to lenalidomide by applying fluorescence in situ hybridization for peripheral blood granulocytes in a patient with 5q- syndrome. J Clin Exp Hematop 62: 158-163, 2022.","DOI":"10.3960\/jslrt.22001"},{"key":"16","unstructured":"16. Nagasawa F, Nakamura Y, Tokita K, et al. Detection of <i>BCR-ABL1<\/i> chimeric gene-positive neutrophils in patients with mixed phenotype acute leukemia. Rinsho Ketsueki 54: 2074-2078, 2013."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Berger R, Chen SJ, Chen Z. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. Cancer Genet Cytogenet 44: 143-152, 1990.","DOI":"10.1016\/0165-4608(90)90041-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Copland M. Treatment of blast phase chronic myeloid leukaemia: a rare and challenging entity. Br J Haematol 199: 665-678, 2022.","DOI":"10.1111\/bjh.18370"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7: e577, 2017.","DOI":"10.1038\/bcj.2017.53"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takahashi N, Miura I, Saitoh K, Miura AB. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase, as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 92: 4758-4763, 1998.","DOI":"10.1182\/blood.V92.12.4758.424k35_4758_4763"},{"key":"21","unstructured":"21. Wood BL. Acute leukaemias of mixed or ambiguous lineage: Introduction. In: Haematolymphoid tumors, WHO classification of tumors, 5th ed. Armed F, Cree IA, de Jong D, Fonseca AFA, Goldman-L\u00e9vy G, Lokuhetty D, Eds. International Agency for Research on Cancer, Lyon, 2024: 203-205."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sun J, Hu R, Han M, et al. Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. Int J Biol Sci 20: 175-181, 2024.","DOI":"10.7150\/ijbs.86305"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kamoda Y, Izumi K, Iioka F, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia is separated into two subgroups associated with survival by BCR-ABL fluorescence in situ hybridization of segmented cell nuclei: report from a single institution. Acta Haematol 136: 157-166, 2016.","DOI":"10.1159\/000445972"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Murai K, Yamaguchi K, Ito S, et al. Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patients. Eur J Haematol 100: 27-35, 2018.","DOI":"10.1111\/ejh.12969"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zhang J, Wang Y, Wang J, et al. Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance. Blood Cancer J 8: 61, 2018.","DOI":"10.1038\/s41408-018-0093-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7790-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:31:34Z","timestamp":1788579094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7790-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7790-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7790-26"}}